Wuxi Business Delegation: Exploring Synergies in Food Processing & Pharmaceuticals

Bühler Group 布勒集团 

AstraZeneca 阿斯利康

Company Profile:

Billions of people come into contact with Bühler technologies to cover their basic needs for food and mobility every day. Bühler develops the best process solutions along complete value chains. Bühler has two business pillars: Grains & Food solutions ensure safe and healthy food and feed. Advanced Materials contributes to the production of energy-efficient vehicles and buildings. As a Swiss company with a history of more than 160 years, Bühler is active in 140 countries around the world and operates a global network of 105 service stations, 27 manufacturing sites, and Application Centers in 26 locations globally. Bühler invests up to 5% of turnover into research and development. In 2023, 12,000 employees generated a turnover of CHF 2.8 billion. 

公司简介：

每天，数以亿计的人们都在享用布勒技术，满足自己在食品和交通出行领域的日常所需。布勒致力于在整个价值链中开发卓越的工艺解决方案，拥有两大业务支柱：谷物食品解决方案，确保安全和健康的食品与饲料；先进材料解决方案，致力于生产节能车辆和建造节能建筑。作为一家拥有160多年历史的瑞士企业，布勒活跃于全球140个国家，拥有包含27个生产基地和105家客户服务中心的全球网络，同时在全球26个地区拥有应用与培训中心。每年布勒将营业额的5%用于研发。2025年，来自于布勒全球的12,000 多名员工创造了28亿瑞士法郎的销售额。

Company Profile:

During the 2019 Boao Forum, Wuxi High-tech Zone signed a strategic cooperation memorandum with AstraZeneca, a global leading biopharmaceutical company, officially announcing the joint establishment of the Wuxi International Life Science Innovation Park（iCampus） under the vision of "Connecting Global Wisdom, Benefiting Healthy China." The park is operated by Wuxi Life Science Industry Development Co., Ltd. Today, it serves as an incubation and innovation platform for domestic and international innovative companies in the life sciences sector, integrating R&D and innovation, achievement commercialization, smart exhibition, and professional services. Leveraging an innovative public-private partnership model, the park has continuously enhanced its functional capabilities and has attracted over 100 life science innovation enterprises from home and abroad. It aims to build an international innovation ecosystem with strong incubation capacity and global synergy, driving Chinese innovation to start in Wuxi, serve China, and benefit the world.

公司简介：

2019年博鳌论坛期间，无锡高新区与全球领先的生物制药企业阿斯利康签署战略合作备忘录，正式宣布共建"凝聚全球智慧·惠及健康中国"的无锡国际生命科学创新园。无锡国际生命科学创新园由无锡生命科学产业发展有限公司负责运营。目前，无锡国际生命科学创新园已成为面向生命科学领域国内外创新公司，打造集研发创新、成果转化、智能展示、专业服务为一体的孵化创新平台，凭借创新的政企合作模式，不断完善职能建设，已吸引超百余家海内外生命科学创新企业入驻，打造具有创新孵化能力、全球协同能力的国际创新生态圈体系，促进中国创新从无锡起步，服务中国、惠及全球。